Table V.

Association between AXL expression and clinicopathological factors in patients with NSCLC.

Clinicopathological factor	Cases, n (n=134)	AXL expression		Positive rate, %	P-value
		–	+
Gender
Male	99	42	57	57.6	0.242
Female	35	19	16	45.7
Age, years
≤60	58	25	33	56.9	0.727
>60	76	36	40	53.6
Histological type
Adenocarcinoma	67	31	36	53.7	1.000
Squamous cell carcinoma	67	30	37	55.2
Degree of differentiation
High	23	17	6	26.1	0.001a
Middle	73	37	36	49.3
Low	38	7	31	81.6
TNM classification
I	23	17	6	26.1	0.005a
II/III/IV	111	44	67	60.4
Lymphatic metastasis
Yes	60	23	37	61.7	0.092
No	74	38	36	48.7
Tumor size, cm
≤3	48	26	22	45.8	0.167
>3	86	35	51	59.3

^aP<0.05. NSCLC, non-small cell lung cancer.